Young joined William Blair in May 2026 as part of a broader investment in the firm’s equities platform. With 25 years of ...

William Blair initiated research coverage of Vor Biopharma Inc. (VOR $18.04), a clinical-stage biotechnology company ...

William Blair acted as the exclusive financial advisor to Morgan Stanley Capital Partners (MSCP) in connection with the acquisition of The Rapid Group (TRG). The transaction closed on October 15, 2026 ...

William Blair today announced that C.J. Jaskoll has joined the firm as chief technology officer, leading William Blair’s firmwide strategy to leverage artificial intelligence, data analytics, and ...

William Blair initiated research coverage of Midera Food Processing, Inc. (MFP $39.57), a leading provider of further and end-of-line food processing solutions to customers operating in the protein, ...

William Blair initiated research coverage of Marex Group Limited (MRX $71.95), a high-growth diversified specialty brokerage ...

Philanthropic giving has reached historic highs, trillions of dollars are expected to transfer across generations in the coming years, and public charities are being called upon to address ...

U.S. biopharma entered the third quarter with meaningful momentum, though the market became more selective as the quarter progressed. The XBI reached a five-year high of approximately $170 in August ...

William Blair acted as the exclusive financial advisor to Brakebush Brothers, Inc. (Brakebush), in connection with its pending sale to Hormel Foods Corporation (NYSE: HRL) (Hormel Foods) for $1.055 ...